---
title: "Avalon Technologies Allots 7,188 Equity Shares Under ESOP Plan"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/278828424.md"
description: "Avalon Technologies Allots 7,188 Equity Shares Under ESOP Plan"
datetime: "2026-03-12T06:15:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278828424.md)
  - [en](https://longbridge.com/en/news/278828424.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278828424.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/278828424.md) | [English](https://longbridge.com/en/news/278828424.md)


# Avalon Technologies Allots 7,188 Equity Shares Under ESOP Plan

Avalon Technologies Allots 7,188 Equity Shares Under ESOP Plan

### 相關股票

- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md)
- [Direxion S&P Biotech Bull 3X (LABU.US)](https://longbridge.com/zh-HK/quote/LABU.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [Avalo Therapeutics (AVTX.US)](https://longbridge.com/zh-HK/quote/AVTX.US.md)
- [Avalon (AWX.US)](https://longbridge.com/zh-HK/quote/AWX.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [Avalon GloboCare (ALBT.US)](https://longbridge.com/zh-HK/quote/ALBT.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-HK/quote/IBBQ.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md)

## 相關資訊與研究

- [EXCLUSIVE: Avalon Teams Up With AWS Partner To Build Automated Video Platform](https://longbridge.com/zh-HK/news/281190322.md)
- [09:00 ETDelonix Bioworks Announces Initiation of Phase 1 First-in-Human Clinical Trial of a Next-Generation MenB OMV Vaccine DX-104](https://longbridge.com/zh-HK/news/281025352.md)
- [Ultragenyx clears IND for UX016 to advance Phase 1/2 GNEM study funded by patient group](https://longbridge.com/zh-HK/news/281024362.md)
- [Avalon GAAP EPS of -$0.09, revenue of $21.48M](https://longbridge.com/zh-HK/news/279850693.md)
- [Teva Pharmaceutical Gets US FDA Approval for Prolia Biosimilar; Xoliar Biosimiliar Applications Accepted in US, Europe](https://longbridge.com/zh-HK/news/281026919.md)